“…For perfectly mixed reactions, one CSTR can be implemented for reactions with a specific network or a cascade of CSTRs to handle a wide range of reactions, kinetics, and phases. Some specific continuous and intensified examples (shown in Figure ) and applications of these (and related) reactor categories include plate microreactors, − oscillatory flow reactors, − coiled flow inverters, − micro packed bed reactors, , plug flow reactors with static mixer inserts, − mixed-suspension mixed-product-removal (MSMPR) crystallizers, , and miniaturized CSTRs . Thus, pharmaceutical processes may be intensified through these three targets: - intensification of the synthesis route via more direct and higher-yield pathways;
- reactor technologies , often miniaturized, with high surface-to-volume ratios and reduced transport lengths that facilitate the use of the intensified reactions in target 1;
- increased productivity through continuous processing with a high degree of automation and RTRT.
When all three targets are incorporated into the design of a pharmaceutical process, the result is a higher-yield, higher-productivity continuous process that can run relatively autonomously and with a smaller footprint than typical batch or semibatch processes.…”